|
|
|
 |
| SuperlativeBio |
|
|
|
"We Provide Superlative Biosciences Services."
|
Superlative BioSciences Corporation
4734 Sabre Lane
Manlius, New York 13104
315-383-3496
|
| Business & Grant Writing Services |
♦ Specializing in National Institutes of Health American Recovery & Reinvestment Act of 2009 (ARRA) Grants Preparation & Submission - Application Due Dates Remaining:
RFA-RR-09-007 - Recovery Act Limited Competition: Core Facility Renovation, Repair, and Improvement (G20)
- Note: SEPTEMBER 17, 2009 RECEIPT DATE
RFA-RR-09-008 - Recovery Act Limited Competition: Extramural Research Facilities Improvement Program (C06)
NOT-RR-09-008 - Addition of Recovery Funds to the Shared Instrumentation Grant Program
RFA-OD-09-007 Recovery Act Limited Competition: Academic Research enhancement Award (R15) RFA OD 09 007
- Note: SEPTEMBER 24, 2009 RECEIPT DATE
RFA-0D-09-008 Recovery Act Limited Competition: Biomedical research, Development, and Growth to Spur the Acceleration of New Technologies (BRDG-SPAN) Pilot Program (RC3)
- Note: SEPTEMBER 1, 2009 RECEIPT DATE
RFA-OD-09-009 Recovery Act Limited Competition: Small Business Catalyst Awards for Accelerating Innovative Research (R43)
- Note: SEPTEMBER 1, 2009 RECEIPT DATE
|
♦ We Also Prepare Standard Small Business Grants and Can Handle All Paper-Based or Web-Based/Electronic Grant Submissions:
SBIRs and STTRs to the United States NIH, NSF, FDA, CDC, EPA, DOD, DOT and DHS
Renewable Energy Grants Preparation and Writing
Preparation of Supplies or Services Contract Proposals to All Agencies
|
Grants Writing to US and International Private Agencies
♦ Superlative Biosciences Corporation Also Provides Consultation On:
The Preparation of Quality Manuals & Other Quality Documents including Change Control, Deviations, CAPA, FMEA, Trending, and Complaint Handling
Advice on Biologics, Pharmaceuticals, Medical Devices, Cell & Tissue Therapy, and Combination Devices Regulatory Guidance
Experienced in FDA/GLP, FDA/QSR, FDA/GMP, ICH, & ISO 9001.
Preparation of SOPS, Master Batch Records (MBRs), CMC and Validation
Advice on FDA Filings (CBER or CDER) & Inspections
♦ Other Business Services Provided Are:
Technology Evaluation
Market Reports
Preparation of Business Plans
Preparation of Marketing Plans
Preparation of Biotechnology & Biomedical Articles and Online Study Guides
|
|
|
| SBIR and STTR Grants Information |
SBIR (Small Business Innovation Research) is a federal government program administered by 12 federal agencies for the purpose of helping to provide early-stage Research and Development funding to small technology companies. Solicitations are released periodically from each of the agencies and present technical topics of R&D which the agency is interested in funding. Companies are invited to compete for funding by submitting proposals that address the technical topic needs of the agency's solicitation. Each of these 12 agencies have various needs and flavors. To learn more about the needs of a particular agency, click on the links in the table below.
STTR (Small Business Technology Transfer) is a smaller scale federal government program similar to SBIR. This program is administered by only 6 federal agencies. The major difference between the SBIR and STTR is that for the STTR the small business is required to work with a not-for-profit research institution or national laboratory on the proposed project.
Latest SBIR/STTR News: The Standard 2009 Solicitation of the NIH, CDC, and FDA for SBIR/STTR Grant Applications due dates are April 5, August 5, and December 5 fon Non-AIDS related topics. AIDS and AIDS-related applications will be due May 7, September 7, 2009, and January 7, 2010.
Superlative Biosciences Corporation can assist companies in applying for the SBIR & STTR programs. We can help you identify which agency or agencies will be interested in your technology, assist with writing and reviewing the proposal. If you need additional information or have any questions or comments, please use the contact form below.
|
| Quality Management Services |
You may use the following form to contact us, or call 315-383-3496.
|
|
|
Preclinical Safety Evaluation of Biopharmaceuticals: A Science-Based Approach to Facilitating Clinical Trials, 2008 Joy A. Cavagnaro covers the entire clinical development continuum from selection of lead candidate to first in human studies to ultimate product approval. It provides an overview of the nature of biopharmaceuticals and the practice of preclinical safety evaluation, including regulations in the US, EU, and Japan. This book is a comprehensive reference book for the preclinical discovery and development scientist whose responsibilities span target identification, lead candidate selection, pharmacokinetics, pharmacology, and toxicology, and for regulatory scientists whose responsibilities include the evaluation of novel therapies.
Biotechnology Venture Capital Valuations, 2006 Biotechnology Venture Capital Valuations is an authoritative, insider's perspective on biotech venture capital for both the venture capitalist and the entrepreneur. Featuring partners, presidents, and CEOs of top venture capital and investment firms. These industry experts discuss their strategies for considering a biotech investment, locating investment opportunity, assessing risk, and negotiating with the entrepreneur, as well as offering different valuation methods for a variety of common scenarios. Publisher: Aspartore Books.
Building Biotechnology: Starting, Managing, and Understanding Biotechnology Companies, 2006 Yale E. Friedman (entrepreneur and business consultant, with a doctorate in biochemistry) provides a guide to the disparate legal, regulatory, commercial, and scientific issues facing those interested in founding and/or managing a biotechnology company. He covers issues of intellectual property and regulation before turning to business issues such as funding; research, development, and marketing; and business development. He also provides a number of chapters covering scientific issues such as drug development, applied research, and research applications.
Startup to IPO: How to Build and Finance a Technology Company, 2004 A practical handbook by Donald H. MacAdam about building a technology company with an emphasis on proven techniques to raise capital at each stage of development. From his personal experience at more than twenty technology companies, Donald H. MacAdam explains the entire process from securing a few hundred thousand dollars in seed financing through the completion of the Initial Public Offering. Of particular interest to entrepreneurs are the step-by-step instructions for raising small or large amounts of money, and the differences between seed round investors, venture capitalists, commercial bankers, and investment bankers in terms of motivation and valuation. An appendix explains how to build a forecast model for a technology company in a format that is acceptable to financial professionals.
Management of Data in Clinical Trials, 2007 From design plan to final analysis, this timely text covers every step of data management in clinical trials. Provides up-to-date information on the planning phase, use of computers and other technology, and training and education. Discusses how to implement Good Clinical Practice and incorporate alternative (and optimal) approaches. Explores differences in how trials are conducted for AIDS, cancer and other major diseases and contrasts European and American approaches. For trials of all sizes and scopes.
Randomised Controlled Trials, 2007 This text by Alejandro R. Jadad, Murray Enkin.is devoted exclusively to all aspects of the randomized controlled trial as a tool for clinical research. The purpose is to inform the reader of the description, uses, pitfalls, advantages, and disadvantages of the randomized controlled trial.
|
| Quality Products and Services |
|
Get a FREE BlackBerry Pearl or Curve (Multimedia) Phone, or a LG Shine or Vu Phone with a new AT&T account.
Please go to www.alwaysonconnect.com
|
|
| © Copyright 2008-2009 Superlative BioSciences Corporation. All Rights Reserved.
|
|
|
|
| |
|
